
3D Biotek LLC Profile last edited on: 4/1/2015
CAGE: 4YGR0
UEI: FJ3JZ8RBUQ51
Business Identifier: Novel 3-dimensional cell culture devices for stem cell/tissue engineering, drug discovery and broad cell biology applications Is this YOUR Company?
Ensure accuracy and completeness of YOUR Company Profile by completing the brief Survey Instrument attached
Do you know about this Awardees?
Let us encourage you to provide any data which would enhance the completeness of this firm's profile.
Location Information
1 Liene Court Suite 8 Unit 12
Hilsborough, NJ 08844
Hilsborough, NJ 08844
(732) 729-6270 |
info@3dbiotek.com |
www.3dbiotek.com |
Location: Single
Congr. District: 07
County: Somerset
Congr. District: 07
County: Somerset
Public Profile
3D Biotek LLC is a biotechnology company using its Precision 3D Micro-Fabrication Technology and Advanced Bio-Manufacturing Technology, to conduct R&D inot novel 3-dimensional (3D) cell culture devices for stem cell/tissue engineering and drug discovery applications. The first product line commercialized by 3D Biotek is the 3D InsertTM, a series of novel 3D porous scaffolds for use in drug screening, stem cell research, and tissue engineering. The application of these 3D InsertTM enables researchers to create superior in vitro models to obtain more realistic physiological results from in vitro studies. As a result, the use of 3D cell culture will decrease the overall therapeutic and pharmaceutical product development cost and shorten the time to market. In April 2010, through 3D Biotek's collaboration with BioCellChallenge, a French company specializing in intracellular delivery systems, the world's only Cell Transfection Kit was made available to researchers worldwide. The kit is based on a unique in vitro transfection technology, allowing researchers to achieve high-density efficiencies of plasmid DNA into 3D-cultured cells and to perform extended 3D transgene expression studies in cell grown in physiological-like tissue environments. 3D Biotek is further developing additional novel products and technologies to overcome current challenges in multiple medical fields, such as orthopedic and angioplasty field, as well as offers services to customers who need to fabricate custom biomedical devices.
Extent of SBIR involvement
Synopsis: Awardee Business Condition
Employee Range
5-9Revenue Range
.5M-1MVC funded?
NoPublic/Private
Privately HeldStock Info
----IP Holdings
10-14Awards Distribution by Agency
Most Recent SBIR Projects
Year | Phase | Agency | Total Amount | |
---|---|---|---|---|
2014 | 1 | NSF | $225,000 | |
Project Title: A novel biomimetic nanofiber coating on dental implants for gingival regeneration | ||||
2012 | 1 | NIH | $237,965 | |
Project Title: Totally Bioresorbable Drug-Eluting Peripheral Polymer Stents | ||||
2009 | 1 | NIH | $99,902 | |
Project Title: A Bio-Manufacturing Process For Fabrication Of 3d Scaffolds With Cell Culture Der |
Key People / Management
Win Lau -- COO
Qing Liu -- CSO
Qing Liu -- CSO